Learner’s Digest International (TM)

  • Antibodies, Antinuclear
  • Arthritis, Juvenile
  • Arthritis, Reactive
  • Cystic Fibrosis

Rheumatology/Cystic Fibrosis

The goal of this program is to improve the management of arthritis in pediatric patients and treatment of cystic fibrosis (CF) in the pediatric population. After hearing and assimilating this program, the clinician will be better able to: 1. Use the antinuclear antibody test to assess risk for uveitis in pediatric patients with juvenile idiopathic arthritis. 2. List differential diagnoses associated with postinfectious arthritis in pediatric patients. 3. Characterize symptoms associated with CF. 4. Differentiate among classes of mutation associated with CF. 5. Optimize use of sweat chloride measurements in diagnosis of CF.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABP — Lifelong Learning and Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider · audio-digest.org

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Nov 2, 2028 2 years left